Ehsan Arkin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ehsan Arkin has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
Ann-Céline Clabout
Laboratory for Virology and Gene Therapy, Department of Pharmacy and Pharmaceutical Sciences, KU Leuven, Leuven, Belgium
1 shared publication- Anna Barber Janer
Laboratory for Neurobiology and Gene Therapy, Department of Pharmacy and Pharmaceutical Sciences, KU Leuven, Leuven, Belgium
1 shared publication - Dieter Plessers
KU Leuven
1 shared publication - Gabriela Mercado
Department of Neurodegenerative Science, Van Andel Institute, Grand Rapids, MI, USA
1 shared publication - Jennifer A. Steiner
Department of Neurodegenerative Science, Van Andel Institute, Grand Rapids, MI, USA
1 shared publication Patrik Brundin
Parkinson's Disease Center, Department of Neurodegenerative Science, Van Andel Institute, Grand Rapids, MI, USA
1 shared publication
Latest Publications
- Open Access
- 27 December 2024
- Published by SAGE Publications in Journal of Parkinson’s Disease
- Vol. 14 (8) , 1559-1574
Chronic urinary tract infections cause persistent microglial changes in a humanized ɑ-synuclein mouse model
Background: Urinary tract infections (UTIs) have recently been linked to the onset of multiple synucleinopathies including Parkinson's disease (PD) and multiple system atrophy (MSA). UTIs are more common in people with PD or MSA, than in the general population and within these patient groups the incidence of UTIs is evenly distributed between men and women. UTIs are especially common during disease, but also in the years before clinical diagnosis. Objective: The mechanisms by which UTIs may contribute to the development and progression of PD or MSA are not well understood. In this work, we evaluate the neuroinflammatory effects of recurrent UTIs on the brain. Methods: In a humanized mouse model of ɑ-synuclein, we find that repeated administration of uropathogenic E. coli result in sustained UTIs, or a non-resolving chronic UTI phenotype with persistent bacteriuria. Using this model, we investigate the effects of repeated chronic UTIs on neuroinflammation and synucleinopathy in the brain. Results: Recurrent UTIs lead to behavioral motor changes and are accompanied by persistent neuroinflammatory changes in multiple brain areas. Affected regions with microglial changes involve multiple lower brainstem areas responsible for sickness behavior, including the dorsal vagal complex, and the cingulate cortex. Conclusions: These results suggests that recurrent UTIs can have lasting impact on the brain, and it warrants further investigation of the potential role of UTIs in the disease progression of synucleinopathies and related neurological disorders.
- 27 December 2024
- Published by SAGE Publications in Journal of Parkinson’s Disease
- Vol. 14 (8) , 1559-1574
Open AccessChronic urinary tract infections cause persistent microglial changes in a humanized ɑ-synuclein mouse model
Background: Urinary tract infections (UTIs) have recently been linked to the onset of multiple synucleinopathies including Parkinson's disease (PD) and multiple system atrophy (MSA). UTIs are more common in people with PD or MSA, than in the general population and within these patient groups the incidence of UTIs is evenly distributed between men and women. UTIs are especially common during disease, but also in the years before clinical diagnosis. Objective: The mechanisms by which UTIs may contribute to the development and progression of PD or MSA are not well understood. In this work, we evaluate the neuroinflammatory effects of recurrent UTIs on the brain. Methods: In a humanized mouse model of ɑ-synuclein, we find that repeated administration of uropathogenic E. coli result in sustained UTIs, or a non-resolving chronic UTI phenotype with persistent bacteriuria. Using this model, we investigate the effects of repeated chronic UTIs on neuroinflammation and synucleinopathy in the brain. Results: Recurrent UTIs lead to behavioral motor changes and are accompanied by persistent neuroinflammatory changes in multiple brain areas. Affected regions with microglial changes involve multiple lower brainstem areas responsible for sickness behavior, including the dorsal vagal complex, and the cingulate cortex. Conclusions: These results suggests that recurrent UTIs can have lasting impact on the brain, and it warrants further investigation of the potential role of UTIs in the disease progression of synucleinopathies and related neurological disorders.